FY2026
Effective from
- Added
Secondary hyperoxaluria
Category — select a more specific code
CDC/NCHS · FY2026primary hyperoxaluria (E72.53-)
Ehlers-Danlos syndromes (Q79.6-)
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2025-10-01
Latest recorded change · FY2026
Effective from
Secondary hyperoxaluria
Category — select a more specific code
CDC/NCHS · FY2026| All editions | Effective from | Code history |
|---|---|---|
| FY2026 | 2025-10-01 | Added |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
primary hyperoxaluria (E72.53-)
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Ehlers-Danlos syndromes (Q79.6-)
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| E72.50 | Disorder of glycine metabolism, unspecified | Billable / specific |
| E72.51 | Non-ketotic hyperglycinemia | Billable / specific |
| E72.52 | Trimethylaminuria | Billable / specific |
| E72.53 | Primary hyperoxaluria | Category · further specificity required |
| E72.59 | Other disorders of glycine metabolism | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗
Excludes 1 · secondary hyperoxaluria (E72.54-)
Excludes 1 · secondary hyperoxaluria (E72.54-)